Angela Bardotti

Title: Angela Bardotti: Innovator in Saccharide Research

Introduction

Angela Bardotti is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of saccharide research, particularly in the development of modified capsular saccharides and their applications in pharmaceuticals. With a total of five patents to her name, Bardotti's work has the potential to impact vaccine development and therapeutic strategies.

Latest Patents

Angela Bardotti's latest patents include innovative methods for modifying saccharides. One notable patent focuses on modified capsular saccharides that incorporate a blocking group at a hydroxyl group position on at least one of the monosaccharide units. This invention outlines processes for creating saccharide-protein conjugates and pharmaceutical compositions that utilize these modified saccharides. Another significant patent addresses the measurement of the degree of polymerization for meningococcal capsular saccharides containing sialic acid. This method is crucial for analyzing saccharide antigens, particularly in glycoconjugates.

Career Highlights

Throughout her career, Angela Bardotti has worked with leading companies in the pharmaceutical industry, including Novartis AG and Novartis Vaccines and Diagnostics Srl. Her expertise in saccharide research has positioned her as a key figure in the development of innovative solutions for public health challenges.

Collaborations

Angela has collaborated with notable colleagues such as Daniela Proietti and Stefano Ricci. These partnerships have further enhanced her research and contributed to the advancement of her projects.

Conclusion

Angela Bardotti's contributions to saccharide research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in vaccine development and therapeutic applications.